Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$219M Buy
17,309,811
+93,130
+0.5% +$1.37M ﹤0.01% 1507
2025
Q3
$265M Buy
17,216,681
+233,434
+1% +$3.76M ﹤0.01% 1397
2025
Q2
$267M Buy
16,983,247
+37,955
+0.2% +$575K ﹤0.01% 1363
2025
Q1
$324M Sell
16,945,292
-258,429
-2% -$5.65M 0.01% 1236
2024
Q4
$410M Buy
17,203,721
+2,009,937
+13% +$56.1M 0.01% 1159
2024
Q3
$425M Buy
15,193,784
+1,896,258
+14% +$53.6M 0.01% 1128
2024
Q2
$348M Buy
13,297,526
+3,043
+0% +$63.3K 0.01% 1180
2024
Q1
$291M Buy
13,294,483
+45,977
+0.3% +$985K 0.01% 1293
2023
Q4
$308M Sell
13,248,506
-27,364
-0.2% -$551K 0.01% 1271
2023
Q3
$262M Sell
13,275,870
-115,797
-0.9% -$2.28M 0.01% 1293
2023
Q2
$304M Buy
13,391,667
+456
+0% +$9.18K 0.01% 1236
2023
Q1
$263M Buy
13,391,211
+2,029,205
+18% +$38.9M 0.01% 1302
2022
Q4
$195M Buy
+11,362,006
New +$202M 0.01% 1445

Other funds holding RXO

Vanguard Group's RXO Position: Q4 2025 in Review

Vanguard Group increased its RXO (RXO) stake by 0.54% in Q4 2025, buying an estimated $1.37M and bringing the position to 17,309,811 shares worth $219M. The position accounts for ﹤0.01% of the portfolio, ranked #1507.

Vanguard Group first reported a position in RXO in Q4 2022 and has held it in 13 quarters since. The position peaked at $425M in Q3 2024. 269 funds tracked by Wall St. Rank hold RXO as of Q4 2025.

  • Vanguard Group held 17,309,811 shares of RXO worth $219M as of Q4 2025.
  • Vanguard Group bought 93,130 RXO shares in Q4 2025, an estimated $1.37M.
  • RXO made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1507 holding.
  • Vanguard Group first reported a position in RXO in Q4 2022 and has held it in 13 quarters since.
  • Vanguard Group's RXO position peaked at $425M in Q3 2024.
  • 269 funds tracked by Wall St. Rank held RXO as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.